Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Lexicon Pharmaceuticals, Inc. LXRX

Set alert

Price alert · LXRX

All alert types
1.44 USD +0.02 +1.41%

At close · Nov 2

1.44 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
1.43 × 1
Ask
1.44 × 1
1.40 Day range 1.45
1.10 52-week range 2.68
YTD
+25.22%
1 year
+4.35%
Open
1.44
Prev close
1.42
Mkt cap
640.74M
Vol
2.02M
Avg vol
2.71M
EPS
-0.16
P/E
0.00
Div yield
0.00%
More statistics
Low
1.40
High
1.45
Forward P/E
-11.86
Beta
1.03
Short ratio
11.53
Inst. own
83.69%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
2.33
200-d avg
1.78
1y target
3.86

5D chart

Chart tools
Interval
1m5m15m30m

Signals (52)
NameTimeAgo
SMA: BearishNov 2, 9:35 AM20 hours ago
RSI: OverboughtOct 30, 3:50 PM3 days ago
RSI: OverboughtOct 30, 3:25 PM3 days ago
MACD: Buy SignalOct 30, 2:30 PM3 days ago
MACD: Sell SignalOct 30, 1:30 PM3 days ago
RSI: OversoldOct 30, 1:20 PM3 days ago
MACD: Buy SignalOct 30, 12:50 PM3 days ago
MACD: Sell SignalOct 30, 11:40 AM3 days ago
SMA: BearishOct 30, 11:30 AM3 days ago
SMA: BullishOct 30, 11:00 AM3 days ago
MACD: Buy SignalOct 30, 10:55 AM3 days ago
RSI: OversoldOct 30, 10:15 AM3 days ago
MACD: Sell SignalOct 30, 9:50 AM3 days ago
RSI: OverboughtOct 29, 3:55 PM4 days ago
MACD: Buy SignalOct 29, 3:30 PM4 days ago
MACD: Sell SignalOct 29, 3:25 PM4 days ago
SMA: BullishOct 29, 2:50 PM4 days ago
MACD: Buy SignalOct 29, 2:50 PM4 days ago
MACD: Sell SignalOct 29, 2:30 PM4 days ago
MACD: Buy SignalOct 29, 2:20 PM4 days ago

Newest 20 of 52.

Analyst view

Consensus: buy

Buy
Price target (mean) 3.86 +167.8% upside
Target (low)
2.00
Target (mean)
3.86
Target (high)
6.00
Ratings (0m) 5 3 buy · 2 hold · 0 sell
  • Strong buy1
  • Buy2
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5
  • 2 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

LXRX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.0529-0.06 – -0.04-0.04-32.3%2.83M-80.0%3
Next quarter-0.03607-0.04 – -0.03-0.04+9.8%13.31M+142.3%3
Current year-0.16632-0.18 – -0.15-0.14-18.8%37.95M-23.8%3
Next year-0.1906-0.27242 – -0.11-0.16632-14.6%19.91M-47.5%4

Upgrades and downgrades

The latest rating changes

LXRX analyst upgrades and downgrades
DateFirmActionFromTo
May 11, 2026CitigroupMaintainedBuyBuy
Mar 23, 2026HC Wainwright & Co.ReiteratedBuyBuy
Mar 10, 2026CitigroupMaintainedBuyBuy
Mar 5, 2026HC Wainwright & Co.MaintainedBuyBuy
Sep 2, 2025HC Wainwright & Co.ReiteratedBuyBuy
Aug 7, 2025CitigroupMaintainedBuyBuy
Jun 24, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 28, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 7, 2025Piper SandlerMaintainedOverweightOverweight
Mar 7, 2025NeedhamReiteratedHoldHold
Mar 7, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 4, 2025Leerink PartnersDowngradeOutperformMarket Perform
Mar 3, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 3, 2025NeedhamReiteratedHoldHold
Jan 29, 2025HC Wainwright & Co.ReiteratedBuyBuy
Jan 29, 2025NeedhamReiteratedHoldHold
Dec 23, 2024NeedhamReiteratedHoldHold
Nov 25, 2024NeedhamReiterated—Hold
Nov 22, 2024NeedhamReiterated—Hold
Nov 13, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 13, 2024NeedhamReiterated—Hold
Nov 5, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 1, 2024HC Wainwright & Co.MaintainedBuyBuy
Nov 1, 2024NeedhamReiterated—Hold
Oct 30, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 30, 2024NeedhamReiterated—Hold
Oct 23, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 17, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 3, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 27, 2024HC Wainwright & Co.ReiteratedBuyBuy